سعر رينجر لاكتات (صوديوم لاكتات مركب) اولمد محلول وريدي بغطاء مطاطي 500 مل 2026

Compound sodium lactate (Ringer's lactate) solution for intravenous infusion, 500 ml, used as a fluid and electrolyte replenisher.

• Source of water and electrolytes or alkalinizing agentPopulation: Adults and pediatric patientsDailyMed (US National Library of Medicine)

• Infusion site reactions (phlebitis, extravasation, inflammation, swelling, rash, pruritus, erythema, pain, burning).International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Hypersensitivity/infusion reactions (angioedema, chest discomfort, tachy- or bradycardia, hypotension, bronchospasm, dyspnea, urticaria, rash, fever, headache).International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Hyperkalemia, hyponatremia, hypervolemia and hyponatremic encephalopathy.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Neonates (28 days of age or younger) receiving ceftriaxone, even via separate lines (fatal ceftriaxone-calcium precipitation).International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Known hypersensitivity to any component.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Air embolism risk with pressurized infusion or series connection of flexible containers.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Hypersensitivity reactions including anaphylaxis and angioedema; stop infusion immediately if they occur.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Hyperkalemia risk in predisposed patients (severe renal impairment, dehydration, burns, heart failure, hyperkalemia-associated drugs); potassium content is insufficient to treat severe hypokalemia.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• CeftriaxoneCalcium-ceftriaxone precipitation; contraindicated together in neonates; in older patients give sequentially with thorough line flushing.DailyMed (US National Library of Medicine)
• Hyperkalemia-associated drugs (potassium-sparing diuretics, ACE inhibitors, ARBs, calcineurin inhibitors)Increased risk of severe hyperkalemia; avoid or monitor serum potassium.DailyMed (US National Library of Medicine)
• Drugs associated with hyponatremia (diuretics, SIADH-inducing drugs)Increased risk of hyponatremia; avoid or monitor serum sodium.DailyMed (US National Library of Medicine)

• Used for decades during labor and delivery; exposure in pregnancy is not expected to cause major birth defects, miscarriage or adverse maternal or fetal outcomes; no animal reproduction studies.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Not expected to harm a breastfed infant; no data on presence in human milk.International label, equivalent formulation · DailyMed (US National Library of Medicine)